ARCHIVES

Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals

This article is from The Cancer Letter archive.

Vol. 09 No. 12 | March 25, 1983

Download PDF Visit The Full Archive

Related Articles

House Subcommittee To Hold Hearings On Cancer Program

June 10, 1977

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew

November 25, 1983

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

Letter to the Editor

February 21, 2003